Bacterial meningitis can affect people of any age, but it is especially common in very young children and adults over 65. The illness often begins with fever and can progress to signs like neck stiffness and other classic exam findings. This page guides you through how cerebrospinal fluid and blood tests confirm the diagnosis, and how organism patterns by age and region inform empiric therapy—plus why prompt antibiotics and adjunctive steroids can change outcomes.
Key Takeaways
- Fever occurs in 95% of bacterial meningitis patients, often >39°C due to hypothalamic inflammation
- Neck stiffness (nuchal rigidity) present in 80-90% of adults with bacterial meningitis, elicited by passive neck flexion
- Kernig's sign positive in 50-70% (pain on knee extension with hip flexed 90°)
- CSF WBC >1,000/mm³ with >80% neutrophils in 85% of bacterial meningitis cases
- CSF Gram stain positive in 60-90% for untreated bacterial meningitis, sensitivity higher for high bacterial load
- CSF glucose <40 mg/dL or <40% serum in 60-80%, protein >100 mg/dL in 80-90%
- Globally, bacterial meningitis causes an estimated 250,000 deaths annually, primarily in children under 5 years and adults over 65
- In the United States, the incidence of bacterial meningitis decreased by 99% for Haemophilus influenzae type b (Hib) after vaccine introduction in 1988-1991, from 12 cases per 100,000 children under 5 to 0.1 per 100,000
- Streptococcus pneumoniae accounts for 58% of bacterial meningitis cases in US adults aged 18-34 years
- Ceftriaxone 2g IV q12h is first-line empiric therapy for adults, covering 95% of pathogens
- Vancomycin 15-20 mg/kg IV q8-12h added empirically for pneumococcal resistance (10-30% in some areas)
- Dexamethasone 0.15 mg/kg q6h x4 days reduces mortality by 30% in Hib/pneumococcal meningitis in high-income countries
- Neisseria meningitidis invades the nasopharynx, crossing the mucosal barrier via pili and opacity proteins to enter the bloodstream
- Streptococcus pneumoniae uses pneumolysin toxin to disrupt endothelial tight junctions in the blood-brain barrier, facilitating meningeal invasion
- Haemophilus influenzae type b capsule (polyribosyl ribitol phosphate) resists phagocytosis, promoting bacteremia and CNS entry
Most adults with bacterial meningitis have fever and neck stiffness, and prompt antibiotics save lives.
Related reading
01 · Category
Clinical Presentation27 stats
01
Fever occurs in 95% of bacterial meningitis patients, often >39°C due to hypothalamic inflammation
02
Neck stiffness (nuchal rigidity) present in 80-90% of adults with bacterial meningitis, elicited by passive neck flexion
03
Kernig's sign positive in 50-70% (pain on knee extension with hip flexed 90°)
04
Brudzinski's sign observed in 40-60% (involuntary hip flexion on neck flexion)
05
Headache described as severe, thunderclap-like in 90% of cases, often frontal or occipital
06
Photophobia reported in 70% of patients, due to meningeal irritation of trigeminal pathways
07
Altered mental status (confusion, lethargy) in 75% of adults, Glasgow Coma Scale <13 in severe cases
08
Seizures occur in 20-30% of adults and 40% of children with bacterial meningitis
09
Focal neurological deficits (e.g., cranial nerve palsies) in 15-25%, CN VI most common (abducens palsy)
10
Petechial rash in 50-70% of meningococcal meningitis, non-blanching, purpuric in fulminant cases
11
Nausea and vomiting in 70-80%, projectile due to increased ICP
12
Neonates present with poor feeding (90%), irritability (80%), bulging fontanelle (60%)
13
Elderly may show subtle signs: 50% only fever and confusion, without meningismus
14
Myalgias and arthralgias in 30% from cytokine-mediated inflammation
15
Hearing loss (sensorineural) develops in 10-20% during acute phase
16
Hypotension/shock in 20% of meningococcal cases, Waterhouse-Friderichsen syndrome in 5-10%
17
Papilledema on fundoscopy in 5-10% with elevated ICP >25 cm H2O
18
Children under 18 months rarely show meningismus (<20%), more nonspecific fever/irritability
19
Positive jolt accentuation test (head shake worsens headache) in 97% sensitivity for meningitis
20
Hyperreflexia or opisthotonos in 30% of pediatric cases
21
DIC markers (thrombocytopenia <100k, prolonged PT/PTT) in 15% of severe cases
22
Respiratory distress/ARDS in 10% from sepsis-induced lung injury
23
Coma (GCS<8) predicts 50% mortality in adults
24
Facial nerve palsy in 5-10%, often transient
25
High fever (>40°C) in 40% of pneumococcal meningitis
26
Anorexia and somnolence dominate in 85% of infant presentations
27
Splenomegaly in 20% of meningococcal disease from immune activation
Interpretation
Clinical Presentation Interpretation
In the clinical presentation of bacterial meningitis, fever is nearly universal at 95% and neck stiffness appears in 80 to 90% of adults, making these two findings the strongest early pattern clinicians should recognize.
More related reading
02 · Category
Diagnosis27 stats
01
CSF WBC >1,000/mm³ with >80% neutrophils in 85% of bacterial meningitis cases
02
CSF Gram stain positive in 60-90% for untreated bacterial meningitis, sensitivity higher for high bacterial load
03
CSF glucose <40 mg/dL or <40% serum in 60-80%, protein >100 mg/dL in 80-90%
04
Blood cultures positive in 50-80% prior to antibiotics
05
Latex agglutination for bacterial antigens detects N. meningitidis in 70-100% of CSF samples
06
PCR for bacterial 16S rRNA has 95% sensitivity, 100% specificity in CSF
07
Procalcitonin >0.5 ng/mL distinguishes bacterial from viral meningitis (sensitivity 89%, specificity 89%)
08
CT head before LP abnormal in 30% (effacement, hydrocephalus), but LP safe if no mass effect signs
09
Lumbar puncture opening pressure >180 mm H2O in 50-70% of cases
10
Multilocus sequence typing (MLST) identifies meningococcal clones like ST-11 complex in epidemics
11
Serum CRP >100 mg/L in 95% of bacterial meningitis
12
BioFire FilmArray Meningitis/Encephalitis Panel detects pathogens in 2 hours with 92-99% sensitivity for bacteria
13
Kernig/Brudzinski signs have 5% sensitivity in elderly, low utility alone
14
CSF lactate >3.0 mmol/L has 93% specificity for bacterial etiology
15
Blood PCR for N. meningitidis positive in 80% of culture-negative cases
16
MRI shows meningeal enhancement in 90%, leptomeningeal nodularity in complications
17
India ink negative in bacterial (used for fungal), but Gram stain key
18
Soluble triggering receptor on myeloid cells (sTREM-1) >100 pg/mL indicates bacterial infection
19
Nasopharyngeal swab culture for carriage detection in contacts, positivity 10-20% in outbreaks
20
CSF cytology shows polymorphonuclear predominance (>80%) vs lymphocytic in viral
21
Metagenomic next-generation sequencing identifies bacteria in 40% culture-negative CSF
22
Bacterial meningitis score (age<2mo, seizure, CSF protein>80, peripheral WBC>10k, low CSF glucose) predicts >95% bacterial if ≥1
23
Limulus amebocyte lysate assay for Gram-neg endotoxin in CSF, sensitivity 90% for Hib/meningococcus
24
EEG shows slowing/delta waves in 70%, epileptiform in seizures
25
Chest X-ray for pneumonia source in 20% pneumococcal cases
26
Serum cryptococcal antigen negative helps rule out fungal mimic
27
Intrathecal ceftriaxone achieves CSF levels 20x MIC for most pathogens
Interpretation
Diagnosis Interpretation
For the diagnosis of bacterial meningitis, CSF findings provide the strongest early signal since over 80% of cases show CSF WBC counts above 1,000/mm³ with more than 80% neutrophils and CSF glucose is low in 60 to 80% while protein is high in 80 to 90%.
More related reading
03 · Category
Epidemiology30 stats
01
Globally, bacterial meningitis causes an estimated 250,000 deaths annually, primarily in children under 5 years and adults over 65
02
In the United States, the incidence of bacterial meningitis decreased by 99% for Haemophilus influenzae type b (Hib) after vaccine introduction in 1988-1991, from 12 cases per 100,000 children under 5 to 0.1 per 100,000
03
Streptococcus pneumoniae accounts for 58% of bacterial meningitis cases in US adults aged 18-34 years
04
Neisseria meningitidis serogroup B causes 60-70% of meningococcal disease cases in Europe among adolescents and young adults
05
In sub-Saharan Africa's meningitis belt, annual incidence of meningococcal meningitis reaches 1,000 cases per 100,000 population during epidemics
06
Mortality rate from bacterial meningitis in neonates is 10-20%, rising to 30% in those with Gram-negative organisms
07
In low-income countries, bacterial meningitis has a case-fatality rate of 20-30%, compared to 5-10% in high-income settings
08
African meningitis belt sees over 250,000 suspected cases yearly, with bacterial etiology confirmed in 50-70%
09
US incidence of pneumococcal meningitis is 1.33 cases per 100,000 adults annually
10
Globally, 1 in 6 people with bacterial meningitis die, and 1 in 5 survivors have severe complications
11
Hib meningitis incidence fell from 20 per 100,000 to <0.1 per 100,000 in vaccinated populations
12
Meningococcal disease incidence in US is 0.11 cases per 100,000 population (2015-2018 average)
13
Bacterial meningitis comprises 80% of acute meningitis cases in adults in developing countries
14
In Brazil, pneumococcal meningitis represents 70% of cases, with 20% mortality
15
Neonatal bacterial meningitis incidence is 0.25-0.38 per 1,000 live births in developed countries
16
Listeria monocytogenes causes 20% of meningitis in immunocompromised adults over 60
17
Epidemic meningococcal meningitis in Africa affects 1 million people since 2000
18
Group B Streptococcus causes 50% of early-onset neonatal meningitis
19
In Europe, meningococcal C vaccine reduced serogroup C cases by 95% post-1999
20
Pneumococcal conjugate vaccine (PCV13) reduced invasive pneumococcal disease by 75% in US children under 5
21
Bacterial meningitis peaks in winter months, with 60% of cases November-March in temperate climates
22
Males have 1.5 times higher incidence of bacterial meningitis than females globally
23
In India, bacterial meningitis incidence is 8.9 per 100,000 children under 5
24
Alcoholism increases risk of pneumococcal meningitis by 15-fold
25
Splenectomy raises risk of overwhelming meningococcal infection 100-fold
26
HIV infection elevates bacterial meningitis risk 10-100 times depending on CD4 count
27
In China, N. meningitidis serogroup A vaccine reduced incidence from 20 to 0.17 per 100,000
28
Bacterial meningitis causes 120,000 deaths yearly in children under 5 worldwide
29
US elderly (>65) have pneumococcal meningitis rate of 5.51 per 100,000
30
During 2015-2020, US meningococcal outbreaks involved 40 cases, 5 deaths (12.5% CFR)
Interpretation
Epidemiology Interpretation
From an epidemiology standpoint, bacterial meningitis still causes about 250,000 deaths worldwide each year, with risk highly concentrated by age and organism such as a 10 to 20% neonatal mortality that climbs to 30% for Gram negative causes.
More related reading
04 · Category
Management And Prevention27 stats
01
Ceftriaxone 2g IV q12h is first-line empiric therapy for adults, covering 95% of pathogens
02
Vancomycin 15-20 mg/kg IV q8-12h added empirically for pneumococcal resistance (10-30% in some areas)
03
Dexamethasone 0.15 mg/kg q6h x4 days reduces mortality by 30% in Hib/pneumococcal meningitis in high-income countries
04
Mortality drops from 20% to 10% with adjunctive steroids in adults with pneumococcal meningitis
05
Rifampin 600 mg qd x2 days for meningococcal prophylaxis in close contacts, eradicates carriage in 90%
06
Hib conjugate vaccine (PRP-T) provides 95-100% efficacy after 3 doses in infants
07
PCV13 vaccination reduces invasive pneumococcal disease by 75-90% in children
08
MenACWY vaccine 85-90% effective against serogroups A,C,W,Y for 3-5 years
09
4CMenB vaccine efficacy 75-88% against serogroup B in UK trials
10
Ampicillin 50 mg/kg q6h plus gentamicin for neonatal GBS/Listeria coverage
11
Repeat LP if no improvement in 48h, to document sterilization (95% sterile by day 2)
12
Hypertonic saline (3%) for ICP >20 mmHg, reduces edema in 70% severe cases
13
Mechanical ventilation for GCS<8, PaO2/FiO2<200 in ARDS complicating sepsis
14
Quadrivalent meningococcal vaccine recommended for asplenic patients, efficacy near 90%
15
Hearing screen post-discharge: 10% need cochlear implants from aminoglycoside/ototoxicity
16
Ciprofloxacin 500 mg single dose prophylaxis alternative to rifampin, 95% effective
17
MenQuadfi vaccine immunogenicity >90% for A,C,W,Y in adults
18
GBS vaccine trials (capsular polysaccharide-protein conjugate) show 80% efficacy promise
19
Neurodevelopmental follow-up: 20-50% survivors have cognitive deficits requiring intervention
20
Droplet precautions for first 24h of antibiotics in meningococcal disease
21
Meropenem 2g q8h for beta-lactam allergic patients, covers resistant pneumococci
22
Trivalent ACW135Y polysaccharide vaccine used in African belt, 85% efficacy short-term
23
IVIG 2g/kg considered adjunctive in fulminant meningococcemia, reduces mortality 20%
24
Penicillin G 4MU q4h for sensitive N. meningitidis post-confirmation
25
Serogroup B vaccine (Bexsero) reduces carriage acquisition by 50% in adolescents
26
Acyclovir empiric if HSV suspected, but stopped if CSF PCR negative
27
VP shunt for post-meningitis hydrocephalus in 5-15% pediatric survivors
Interpretation
Management And Prevention Interpretation
For management and prevention of bacterial meningitis, using ceftriaxone 2 g IV every 12 hours as first line with adjunctive dexamethasone when appropriate and adding vancomycin for suspected pneumococcal resistance can cut mortality from 20% to 10% while prevention efforts like rifampin eradication of meningococcal carriage in 90% of close contacts and Hib PRP T vaccine efficacy of 95 to 100% after 3 infant doses help reduce transmission.
More related reading
05 · Category
Pathophysiology24 stats
01
Neisseria meningitidis invades the nasopharynx, crossing the mucosal barrier via pili and opacity proteins to enter the bloodstream
02
Streptococcus pneumoniae uses pneumolysin toxin to disrupt endothelial tight junctions in the blood-brain barrier, facilitating meningeal invasion
03
Haemophilus influenzae type b capsule (polyribosyl ribitol phosphate) resists phagocytosis, promoting bacteremia and CNS entry
04
Group B Streptococcus produces beta-hemolysin/cytolysin, inducing neuronal apoptosis and blood-brain barrier permeability in neonates
05
Listeria monocytogenes employs listeriolysin O to escape phagosomes and spread cell-to-cell, reaching meninges via monocyte trafficking
06
Meningococcal lipopolysaccharide (LOS) triggers massive cytokine storm (TNF-alpha, IL-1, IL-6), leading to septic shock and purpura fulminans
07
Bacterial antigens in CSF provoke neutrophilic influx, causing cerebral edema via increased vascular permeability and cytotoxic edema
08
Increased intracranial pressure from bacterial meningitis exceeds 20 mmHg in 50% of severe cases, risking herniation
09
Autopsy shows subarachnoid pus, ventricular debris, and ependymal necrosis in 70% of fatal pneumococcal meningitis
10
Meningococci form procoagulant microparticles, activating coagulation cascade and causing microvascular thrombosis in 20% of cases
11
CSF glucose drops below 40% of serum in 80% of bacterial meningitis due to bacterial glycolysis and neutrophil consumption
12
Endotoxin release induces NO synthase, causing cerebral vasodilation and hypotension in meningococcal sepsis
13
Hydrocephalus develops in 10-30% of survivors from basilar cistern adhesions and aqueductal stenosis
14
Neuronal injury from pneumolysin correlates with hippocampal apoptosis in animal models
15
Adjunctive dexamethasone reduces CSF TNF-alpha by 70%, mitigating inflammation-mediated damage
16
Blood-brain barrier breakdown measured by CSF/serum albumin ratio >9 indicates severe BBB disruption in 60% cases
17
Meningococcal outer membrane vesicles trigger NLRP3 inflammasome, releasing IL-1beta and exacerbating inflammation
18
Group B Strep hyaluronidase degrades host hyaluronan, aiding extracellular matrix traversal to meninges
19
CSF lactate >3.5 mmol/L reflects anaerobic metabolism from bacterial load and hypoperfusion
20
Cerebral infarction occurs in 15% due to vasculitis and vasospasm from subarachnoid inflammation
21
Hib induces IgA protease to cleave mucosal IgA, facilitating nasopharyngeal colonization
22
Pneumococcal neuraminidase exposes endothelial sialic acid receptors, enhancing adherence
23
Complement deficiencies (C5-C9) increase meningococcal risk 1,000-fold via impaired MAC formation
24
Bacterial DNA in CSF triggers TLR9-mediated pyroptosis in microglia, amplifying damage
Interpretation
Pathophysiology Interpretation
Across these bacterial meningitis examples, multiple pathogens converge on the same pathophysiology theme of breaching host barriers by directly damaging endothelium or evading immunity, with the strongest signal being meningococcal LOS driving a cytokine storm of TNF alpha, IL 1, and IL 6 that culminates in septic shock and purpura fulminans.
report visual · Breakdown
Common presenting findings in bacterial meningitis
Key clinical signs occur in most patients, while several others are less frequent but important for escalation.
95%
Fever occurs in 95% of bacterial meningitis patients, often >39°C due to hypothalamic inflammation
5%
Kernig/Brudzinski signs have 5% sensitivity in elderly, low utility alone
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Bacterial Meningitis Statistics. Gitnux. https://gitnux.org/bacterial-meningitis-statistics
MLA
David Sutherland. "Bacterial Meningitis Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/bacterial-meningitis-statistics.
Chicago
David Sutherland. 2026. "Bacterial Meningitis Statistics." Gitnux. https://gitnux.org/bacterial-meningitis-statistics.
Sources & references
12 datasets cited across this report · attribution is report-level